Literature DB >> 16476054

Cytotoxic herpes simplex type 2-specific, DQ0602-restricted CD4 T+-cell clones show alloreactivity to DQ0601.

Sandra Reichstetter1, Nathan E Standifer, Kelly A Geubtner, Andrew W Liu, Stacy L Agar, William W Kwok.   

Abstract

Alloreactivity is one of the most serious problems in organ transplantation. It has been hypothesized that pre-existing alloreactive T cells are actually cross-reacting cells that have been primed by the autologous major histocompatibility complex (MHC) and a specific peptide. CD8+ cytotoxic T lymphocytes that are alloreactive and recognize a virus-peptide that is presented by the autologous MHC have been reported. Here we demonstrate a cross-reactivity that exists between DQ0602 restricted, herpes simplex type 2 VP16 40-50 specific CD4+ T-cell clones, which can be alloreactive to DQ0601. Though most of the DQ0602 restricted T-cell clones we isolated from two different donors were not alloreactive, weakly cross-reacting T-cell clones could be isolated from both donors. Two strongly cross-reacting T-cell clones with high affinity interaction of their T-cell receptor (TCR) with both DQ0602/VP16 40-50 and DQ0601 could be isolated from one donor. DNA sequencing of the a fragment of the Vbeta gene used in their TCR confirmed that these two T cells indeed are two independent clones. These clones are cytotoxic and produce cytokines of a T helper 2-like pattern. Possible implications in a DR-matched transplantation setting are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476054      PMCID: PMC1782233          DOI: 10.1111/j.1365-2567.2005.02308.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  34 in total

Review 1.  The influence of antiviral T-cell responses on the alloreactive repertoire.

Authors:  S R Burrows; R Khanna; S L Silins; D J Moss
Journal:  Immunol Today       Date:  1999-05

2.  Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor.

Authors:  R Brock; K H Wiesmüller; G Jung; P Walden
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

3.  HLA class II region sequences, 1998.

Authors:  S G Marsh
Journal:  Tissue Antigens       Date:  1998-04

Review 4.  The role of endogenous peptides in the direct pathway of alloreactivity to human MHC class II molecules expressed on CHO cells.

Authors:  G Pawelec; M Adibzadeh; S Bornhak; H Friccius; T Halder; H Kalbacher; K Li; H Max; C Müller; D Sansom; F Thiel; J Zeuthen
Journal:  Immunol Rev       Date:  1996-12       Impact factor: 12.988

Review 5.  Mechanisms of T cell recognition of alloantigen. The role of peptides.

Authors:  M H Sayegh; B Watschinger; C B Carpenter
Journal:  Transplantation       Date:  1994-05-15       Impact factor: 4.939

6.  Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.

Authors:  S R Burrows; S L Silins; R Khanna; J M Burrows; M Rischmueller; J McCluskey; D J Moss
Journal:  Eur J Immunol       Date:  1997-07       Impact factor: 5.532

7.  Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone.

Authors:  K Udaka; K H Wiesmüller; S Kienle; G Jung; P Walden
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

8.  Large clonal expansions of CD8+ T cells in acute infectious mononucleosis.

Authors:  M F Callan; N Steven; P Krausa; J D Wilson; P A Moss; G M Gillespie; J I Bell; A B Rickinson; A J McMichael
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

9.  Human leukocyte antigen phenotype imposes complex constraints on the antigen-specific cytotoxic T lymphocyte repertoire.

Authors:  S R Burrows; S L Silins; S M Cross; C A Peh; M Rischmueller; J M Burrows; S L Elliott; J McCluskey
Journal:  Eur J Immunol       Date:  1997-01       Impact factor: 5.532

10.  HLA matching: identification of permissible HLA mismatches.

Authors:  E Maruya; S Takemoto; P I Terasaki
Journal:  Clin Transpl       Date:  1993
View more
  2 in total

1.  Donor-derived CD4(+)/CCR7(+) T-cell partial selective depletion does not alter acquired anti-infective immunity.

Authors:  B Choufi; J Trauet; S Thiant; M Labalette; I Yakoub-Agha
Journal:  Bone Marrow Transplant       Date:  2014-02-24       Impact factor: 5.483

2.  Alloreactivity across HLA barriers is mediated by both naïve and antigen-experienced T cells.

Authors:  J Joseph Melenhorst; Phillip Scheinberg; Ann Williams; David R Ambrozak; Keyvan Keyvanfar; Melody Smith; J Philip McCoy; Nancy F Hensel; Daniel C Douek; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-06       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.